Leidos(LDOS)
Search documents
Compared to Estimates, Leidos (LDOS) Q4 Earnings: A Look at Key Metrics
Zacks Investment Research· 2024-02-13 15:36
Leidos (LDOS) reported $3.98 billion in revenue for the quarter ended December 2023, representing a year-over-year increase of 7.7%. EPS of $1.99 for the same period compares to $1.83 a year ago.The reported revenue represents a surprise of +4.99% over the Zacks Consensus Estimate of $3.79 billion. With the consensus EPS estimate being $1.73, the EPS surprise was +15.03%.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street ex ...
Leidos (LDOS) Tops Q4 Earnings and Revenue Estimates
Zacks Investment Research· 2024-02-13 13:11
Leidos (LDOS) came out with quarterly earnings of $1.99 per share, beating the Zacks Consensus Estimate of $1.73 per share. This compares to earnings of $1.83 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 15.03%. A quarter ago, it was expected that this security and engineering company would post earnings of $1.64 per share when it actually produced earnings of $2.03, delivering a surprise of 23.78%.Over the last four quarte ...
Leidos(LDOS) - 2023 Q4 - Annual Report
2024-02-12 16:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 29, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-33072 Leidos Holdings, Inc. (Exact name of registrant as specified in its charter) Indicate by check mark if the registrant is a well-known seas ...
Why Leidos (LDOS) is a Top Value Stock for the Long-Term
Zacks Investment Research· 2024-02-12 15:41
It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ways to do both.The popular research service can help you become a smarter, more self-assured investor, giving you access to daily updates of the Zacks Rank and Zacks Industry Rank, the Zacks #1 Rank List, Equity Research reports, and Premium stock screens.Zacks Premium also includes the Zacks Style Scores.What a ...
Leidos and Sourcegraph to bring secure, AI-enabled software development to government customers
Prnewswire· 2024-02-08 21:00
RESTON, Va., Feb. 8, 2024 /PRNewswire/ -- Leidos (NYSE: LDOS), a Fortune 500® innovation company, and Sourcegraph, the leading code intelligence platform, today announced an exclusive alliance to introduce secure, generative AI-enabled software development tools to government customers. "Fireside chat" featuring (L-R) Paul Burnette, Quinn Slack and Ron Keesing during the Leidos and Sourcegraph Alliance Launch event at the Leidos global headquarters on February 6, 2024. Sourcegraph Inc. is a company deve ...
Will High Interest Expense Hurt Leidos' (LDOS) Q4 Earnings?
Zacks Investment Research· 2024-02-08 15:35
Leidos Holdings, Inc. (LDOS) is scheduled to report fourth-quarter and full-year 2023 results on Feb 13, before market open. Leidos has a four-quarter average earnings surprise of 11.51%. Strong revenue performance across the majority of its business segments is likely to have contributed to the overall performance of the company in the fourth quarter. However, higher interest expenses might have hurt earnings.Defense Solution’s Performance May Remain SolidIncreased sales volumes for defensive hypersonics ...
Countdown to Leidos (LDOS) Q4 Earnings: A Look at Estimates Beyond Revenue and EPS
Zacks Investment Research· 2024-02-08 15:21
The upcoming report from Leidos (LDOS) is expected to reveal quarterly earnings of $1.73 per share, indicating a decline of 5.5% compared to the year-ago period. Analysts forecast revenues of $3.79 billion, representing an increase of 2.5% year over year.The consensus EPS estimate for the quarter has remained unchanged over the last 30 days. This represents how the covering analysts, as a whole, have reassessed their initial estimates during this timeframe.Before a company reveals its earnings, it is vital ...
Top 5 Dividend-Paying Stocks Set to Beat on Earnings Next Week
Zacks Investment Research· 2024-02-08 13:01
We are in the middle of the fourth-quarter 2023 earnings season. Results are, so far, mostly in line with expectations. Next week will be the busiest this reporting cycle, with as many as 808 companies slated to report their quarterly financial numbers.As of Feb 7, 285 companies on the S&P 500 Index have reported their financial numbers. Total earnings for these 285 index members are up 4.4% from the same period last year on 3.5% higher revenues, with 81.1% beating EPS estimates and 64.6% beating revenue es ...
Are Investors Undervaluing Leidos (LDOS) Right Now?
Zacks Investment Research· 2024-02-02 15:46
The proven Zacks Rank system focuses on earnings estimates and estimate revisions to find winning stocks. Nevertheless, we know that our readers all have their own perspectives, so we are always looking at the latest trends in value, growth, and momentum to find strong picks.Of these, perhaps no stock market trend is more popular than value investing, which is a strategy that has proven to be successful in all sorts of market environments. Value investors use tried-and-true metrics and fundamental analysis ...
Leidos awarded contract to support ARPA-H
Prnewswire· 2024-01-29 21:30
RESTON, Va., Jan. 29, 2024 /PRNewswire/ -- Leidos (NYSE:LDOS), a Fortune 500® innovation company, was recently awarded a prime contract by the Advanced Research Projects Agency for Health (ARPA-H). The hybrid firm fixed price/time and materials contract was awarded by the U.S. Department of Health and Human Services (HHS) and has a one-year base period of performance and two one-year options. "We are thrilled to work with ARPA-H building the infrastructure and capabilities necessary to drive biomedical brea ...